Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.

Lani Lieberman Jeannie L CallumRobert CohenChristine M Cserti-GazdewichNoor Niyar N LadhaniJonah BucksteinJacob PendergrastYulia Lin

Published in: Transfusion (2020)

Morbidity and mortality related to HDFN was low; most alloimmunized pregnancies needed minimal intervention. Titers of >32 by gel warrant additional monitoring during pregnancy.

Keyphrases

red blood cell
randomized controlled trial
preterm birth
sickle cell disease
gestational age
type diabetes
hyaluronic acid
weight loss